These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25939608)

  • 21. Immune control of HIV-1 reservoirs.
    Autran B; Descours B; Bacchus C
    Curr Opin HIV AIDS; 2013 May; 8(3):204-10. PubMed ID: 23493099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reservoirs for HIV infection and their persistence in the face of undetectable viral load.
    Sonza S; Crowe SM
    AIDS Patient Care STDS; 2001 Oct; 15(10):511-8. PubMed ID: 11689138
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV reservoirs, latency, and reactivation: prospects for eradication.
    Dahl V; Josefsson L; Palmer S
    Antiviral Res; 2010 Jan; 85(1):286-94. PubMed ID: 19808057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What do we need to do to cure HIV infection.
    Siliciano RF
    Top HIV Med; 2010; 18(3):104-8. PubMed ID: 20921575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new model for post-integration latency in macroglial cells to study HIV-1 reservoirs of the brain.
    Schneider M; Tigges B; Meggendorfer M; Helfer M; Ziegenhain C; Brack-Werner R
    AIDS; 2015 Jun; 29(10):1147-59. PubMed ID: 26035317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stochastic variability in HIV affects viral eradication.
    Rouzine IM; Razooky BS; Weinberger LS
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13251-2. PubMed ID: 25201951
    [No Abstract]   [Full Text] [Related]  

  • 27. MicroRNAs and HIV latency: a complex and promising relationship.
    Detsika MG; Psarris A; Paraskevis D
    AIDS Rev; 2012; 14(3):188-94. PubMed ID: 22833062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous HIV-1 replication in a B-lymphoblastoid cell line obtained from an HIV-1-positive patient with undetectable plasma viral load.
    Belmonte L; Parodi C; Bare P; Corti M; Sanjuan N; de Bracco MM; Ruibal-Ares BH
    AIDS; 2006 Jun; 20(9):1340-2. PubMed ID: 16816569
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV eradication symposium: will the brain be left behind?
    Brew BJ; Robertson K; Wright EJ; Churchill M; Crowe SM; Cysique LA; Deeks S; Garcia JV; Gelman B; Gray LR; Johnson T; Joseph J; Margolis DM; Mankowski JL; Spencer B
    J Neurovirol; 2015 Jun; 21(3):322-34. PubMed ID: 25750070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy.
    Horiike M; Iwami S; Kodama M; Sato A; Watanabe Y; Yasui M; Ishida Y; Kobayashi T; Miura T; Igarashi T
    Virology; 2012 Feb; 423(2):107-18. PubMed ID: 22196013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
    Redel L; Le Douce V; Cherrier T; Marban C; Janossy A; Aunis D; Van Lint C; Rohr O; Schwartz C
    J Leukoc Biol; 2010 Apr; 87(4):575-88. PubMed ID: 19801499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of the role of oral epithelial cells and Langerhans cells as possible HIV viral reservoirs.
    Boy SC; van Heerden MB; Wolfaardt M; Cockeran R; Gema E; van Heerden WF
    J Oral Pathol Med; 2009 Jan; 38(1):114-9. PubMed ID: 19192056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lungs as anatomical reservoirs of HIV infection.
    Costiniuk CT; Jenabian MA
    Rev Med Virol; 2014 Jan; 24(1):35-54. PubMed ID: 24151040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hidden HIV reservoirs: will eradication of the virus be possible?
    Gomez E
    Newsline People AIDS Coalit N Y; 1998 Mar; ():18-9. PubMed ID: 11367451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.
    Pomerantz RJ
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):297-306. PubMed ID: 15507870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
    Siliciano RF
    Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro.
    Bedoya LM; Márquez N; Martínez N; Gutiérrez-Eisman S; Alvarez A; Calzado MA; Rojas JM; Appendino G; Muñoz E; Alcamí J
    Biochem Pharmacol; 2009 Mar; 77(6):965-78. PubMed ID: 19100719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment implications of the latent reservoir for HIV-1.
    Peterson S; Reid AP; Kim S; Siliciano RF
    Adv Pharmacol; 2007; 55():411-25. PubMed ID: 17586322
    [No Abstract]   [Full Text] [Related]  

  • 40. Hide-and-seek: the challenge of viral persistence in HIV-1 infection.
    Geeraert L; Kraus G; Pomerantz RJ
    Annu Rev Med; 2008; 59():487-501. PubMed ID: 17845138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.